New asthma inhaler combo shows promise in easing sudden breathing trouble

NCT ID NCT05555290

First seen Jan 31, 2026 · Last updated May 09, 2026 · Updated 8 times

Summary

This study tested whether a new inhaler (PT027) that combines a fast-acting reliever (albuterol) with an anti-inflammatory (budesonide) works better than albuterol alone for sudden asthma attacks. 190 adults with mild asthma who only used rescue inhalers as needed took part. Researchers measured lung function improvements after triggering airway narrowing with a mannitol challenge. The goal was to see if the combination provides faster or stronger relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Columbia, Maryland, 21046, United States

Conditions

Explore the condition pages connected to this study.